LIGHT-INDUCED DNA BASE EXCITATION, DEACTIVATION AND OXIDATION
光诱导 DNA 碱基激发、失活和氧化
基本信息
- 批准号:8166141
- 负责人:
- 金额:$ 9.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:6-MercaptopurineAntineoplastic AgentsAttentionAzathioprineComputer Retrieval of Information on Scientific Projects DatabaseDNADNA DamageDiseaseDrug ControlsEventFundingGrantImmunosuppressive AgentsInflammatoryInstitutionLasersLightMolecularOxygenPhotosensitizationProductionResearchResearch PersonnelResourcesSinglet OxygenSourceTechniquesThioguanineTimeUnited States National Institutes of Healthanalogbasebiological systemsirradiationoxidationphotolysisquantumthiopurine
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Thiopurine DNA base analogues, azathioprine (Aza), 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG) have been used as effective anti-cancer agents, immunosuppressants and control drugs in the treatment of inflammatory disorders for five decades. Nevertheless, fatal threat associated with 6-TG-substituted DNA was also caught attention. The possibility that thiopurines DNA bases and their derivatives of S-methylmercaptopurine (me6-MP) and S-methylthioguanine (me6-TG) thiopurines may act as an endogenous singlet oxygen sensitizer and provide a source of DNA damage promoted us to quantitatively study their photosensitization ability. Photochemical techniques such as time-resolved laser and steady-state photolysis are employed in this study. Our results show that all of these thiopurines possess the ability to produce singlet oxygen with quantum yields ~ 0.4. However, their photosensitization ability was decreased dramatically under light in the presence of oxygen. For the first time, upon UVA irradiation of thiopurines singlet oxygen production was observed directly at 1270 nm and characterized quantitatively. Our results shine new light on the molecular events of thiopurines that may underlie risky activity in biological systems.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
硫嘌呤DNA碱基类似物硫唑嘌呤(Aza)、6-巯基嘌呤(6-MP)和6-硫鸟嘌呤(6-TG)已经被用作有效的抗癌剂、免疫抑制剂和控制药物用于治疗炎性疾病50年。然而,与6-TG取代的DNA相关的致命威胁也引起了人们的注意。硫嘌呤类DNA碱基及其衍生物S-甲基巯基嘌呤(me 6-MP)和S-甲基硫鸟嘌呤(me 6-TG)作为内源性单线态氧敏化剂,可能成为DNA损伤源,这促使我们定量研究它们的光敏化能力。本研究采用了时间分辨激光和稳态光解等光化学技术。我们的研究结果表明,所有这些硫嘌呤具有产生单线态氧的量子产率约0.4的能力。然而,它们的光敏化能力显着下降,在光和氧气的存在下。第一次,在UVA照射的硫嘌呤单线态氧的生产直接观察到在1270 nm和定量表征。我们的研究结果为巯基嘌呤的分子事件提供了新的线索,这些分子事件可能是生物系统中危险活动的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruomei Gao其他文献
Ruomei Gao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ruomei Gao', 18)}}的其他基金
LIGHT-INDUCED DNA BASE EXCITATION, DEACTIVATION AND OXIDATION
光诱导 DNA 碱基激发、失活和氧化
- 批准号:
8357073 - 财政年份:2011
- 资助金额:
$ 9.74万 - 项目类别:
LIGHT-INDUCED DNA BASE EXCITATION, DEACTIVATION AND OXIDATION
光诱导 DNA 碱基激发、失活和氧化
- 批准号:
7959219 - 财政年份:2009
- 资助金额:
$ 9.74万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 9.74万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 9.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 9.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 9.74万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 9.74万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 9.74万 - 项目类别:














{{item.name}}会员




